Miromatrix Medical Inc. (MIRO) Tops Q2 EPS by 5c

Miromatrix Medical Inc. (NASDAQ: MIRO) reported Q2 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $8.52 million versus the consensus estimate of $3.5 thousand.

For earnings history and earnings-related data on Miromatrix Medical Inc. (MIRO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat